We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$826M
AUM Growth
+$80.6M
Cap. Flow
+$192M
Cap. Flow %
23.2%
Top 10 Hldgs %
88.05%
Holding
89
New
11
Increased
19
Reduced
33
Closed
19

Top Buys

1
MS icon
Morgan Stanley
MS
+$19M
2
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$7.97M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$6.5M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$5.06M
5
BMY icon
Bristol-Myers Squibb
BMY
+$4.11M

Top Sells

1
GS icon
Goldman Sachs
GS
+$12.3M
2
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$9.86M
3
CS
Credit Suisse Group
CS
+$5.3M
4
IVW icon
iShares S&P 500 Growth ETF
IVW
+$2.27M
5
GM icon
General Motors
GM
+$1.66M

Sector Composition

1 Healthcare 6.96%
2 Financials 6.75%
3 Consumer Discretionary 2.6%
4 Communication Services 2.54%
5 Industrials 1.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$500M 60.5%
2,000,000
+1,000,000
+100% +$270M
IEF icon
2
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$90.2M 10.92%
865,800
– –
QQQ icon
3
PUT
Invesco QQQ Trust
QQQ
$466B
$30.9M 3.73%
200,000
-450,000
-69% -$75.3M
ATH
4
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$22.1M 2.67%
553,921
+177,000
+47% +$7.97M
HCA icon
5
HCA Healthcare
HCA
$82.3B
$20M 2.42%
160,379
-167
-0.1% -$22.4K
MS icon
6
Morgan Stanley
MS
$339B
$17.2M 2.09%
+434,807
New +$19M
BERY
7
DELISTED
Berry Global Group, Inc.
BERY
$12.1M 1.47%
277,695
+38,568
+16% +$1.65M
GOOG icon
8
Alphabet (Google) Class C
GOOG
$4.22T
$11.9M 1.44%
230,000
– –
DAL icon
9
Delta Air Lines
DAL
$55.4B
$11.7M 1.42%
235,000
+24,044
+11% +$1.31M
JPM icon
10
JPMorgan Chase
JPM
$907B
$11.5M 1.39%
118,019
+23
+0% +$2.45K
GM icon
11
General Motors
GM
$68.6B
$9.4M 1.14%
281,031
-47,981
-15% -$1.66M
APTV icon
12
Aptiv
APTV
$12.2B
$7.7M 0.93%
125,000
+50,000
+67% +$3.62M
CVS icon
13
CVS Health
CVS
$137B
$7.39M 0.89%
112,778
+1,655
+1% +$124K
ZVRA icon
14
Zevra Therapeutics
ZVRA
$755M
$7.29M 0.88%
255,995
+125,000
+95% +$5.06M
PARA
15
DELISTED
Paramount Global Class B
PARA
$6.12M 0.74%
140,000
+40,000
+40% +$2.13M
ZBH icon
16
Zimmer Biomet
ZBH
$17.6B
$5.99M 0.73%
59,512
+14,819
+33% +$1.67M
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
$5.36M 0.65%
+55,000
New +$6.5M
COR icon
18
Cencora
COR
$59.9B
$5.02M 0.61%
67,500
+20,000
+42% +$1.72M
BMY icon
19
Bristol-Myers Squibb
BMY
$124B
$3.98M 0.48%
+76,476
New +$4.11M
BABA icon
20
Alibaba
BABA
$276B
$3.84M 0.46%
28,000
– –
VXX
21
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$3.52M 0.43%
+75,000
New +$2.78M
DFS
22
DELISTED
Discover Financial Services
DFS
$2.24M 0.27%
38,000
– –
GDX icon
23
CALL
VanEck Gold Miners ETF
GDX
$21.8B
$2.11M 0.26%
100,000
– –
LQD icon
24
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35.2B
$1.39M 0.17%
+12,300
New +$1.38M
MSFT icon
25
Microsoft
MSFT
$2.93T
$1.3M 0.16%
12,805
-2,174
-15% -$233K
1
2 3 4

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, DSC Advisors held 89 positions worth $826M, up 11% from $746M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

DSC Advisors deployed $192M of net new capital in Q4 2018, opening 11 new positions and adding to 19 existing holdings. Its largest new stake was Morgan Stanley: 434,807 shares worth $17.2M.

By sector, the portfolio is most concentrated in Healthcare at 7% of assets, down from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares S&P 500 Growth ETF, an estimated $2.27M trimmed.

  • DSC Advisors's largest Q4 2018 buy was Morgan Stanley: 434,807 shares worth $17.2M.
  • DSC Advisors added most to Athene Holding Ltd. Class A Common Shares in Q4 2018, an estimated $7.97M increase.
  • DSC Advisors's biggest Q4 2018 reduction was iShares S&P 500 Growth ETF, cutting an estimated $2.27M.
  • DSC Advisors fully exited Goldman Sachs in Q4 2018, selling an estimated $12.3M.
  • DSC Advisors's ten largest holdings make up 88% of its $826M portfolio in Q4 2018.
  • DSC Advisors opened 11 new positions and closed 19 in Q4 2018.
  • DSC Advisors's portfolio value rose 11% quarter-over-quarter to $826M.

Based on DSC Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.